Sunshine Lake Pharma Co (HKSE:06887) ROCE %: 14.16% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06887 Sunshine Lake Pharma Co Ltd HKSE:06887
15 GF Score
Price HK$38.36
! 2 Warning Signs
View Full Analysis

What is Sunshine Lake Pharma Co ROCE %?

Sunshine Lake Pharma Co HKSE:06887 +2.62% 15 ROCE % is 14.16% as of Dec. 2025. GuruFocus rates HKSE:06887 with a GF Score™ of 15/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sunshine Lake Pharma Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 14.16%.

Sunshine Lake Pharma Co  (HKSE:06887) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sunshine Lake Pharma Co ROCE % Related Terms

Sunshine Lake Pharma Co ROCE % Historical Data

* Premium members only.

The historical data trend for Sunshine Lake Pharma Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Lake Pharma Co ROCE % Chart

Sunshine Lake Pharma Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROCE %
-45.82 42.83 5.54 10.44

Sunshine Lake Pharma Co Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial 0.00 22.41 -10.02 5.97 14.16
HKSE:06887
15GF Score
Sunshine Lake Pharma Co Ltd HKSE:06887
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Lake Pharma Co ROCE % Calculation

Sunshine Lake Pharma Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=739.91/( ( (12738.944 - 5140.041) + (13248.68 - 6670.165) )/ 2 )
=739.91/( (7598.903+6578.515)/ 2 )
=739.91/7088.709
=10.44 %

Sunshine Lake Pharma Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=1015.958/( ( (13186.059 - 5409.838) + (13248.68 - 6670.165) )/ 2 )
=1015.958/( ( 7776.221 + 6578.515 )/ 2 )
=1015.958/7177.368
=14.16 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 14.16% mean?
Sunshine Lake Pharma Co (HKSE:06887) has a ROCE % of 14.16% as of Dec. 2025.
Is Sunshine Lake Pharma Co's ROCE % too high?
Sunshine Lake Pharma Co's current ROCE % is 14.16%. The Drug Manufacturers industry median ROCE % is 7.21. Sunshine Lake Pharma Co's value of 14.16% is 96.5% above this industry median. Overall, Sunshine Lake Pharma Co has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Sunshine Lake Pharma Co's ROCE % compare to ZTS?
Sunshine Lake Pharma Co's ROCE % of 14.16% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.21. Sunshine Lake Pharma Co's value of 14.16% is 96.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.21, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunshine Lake Pharma Co's current ROCE % of 14.16% is 96.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Lake Pharma Co's current ROCE % is 14.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Lake Pharma Co stock overvalued right now?
Sunshine Lake Pharma Co (HKSE:06887) has a current ROCE % of 14.16%. The current ROCE % is 14.16% and 96.5% above the Drug Manufacturers industry median of 7.21. Sunshine Lake Pharma Co's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sunshine Lake Pharma Co (HKSE:06887), the current ROCE % is 14.16% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunshine Lake Pharma Co Business Description

Address No. 368 Zhen An Zhong Road, HEC Scientific Park, Chang’an County, Guangdong Province, Dongguan, CHN
Sunshine Lake Pharma Co Ltd is a vertically integrated pharmaceutical company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. It is focused on therapeutic areas of infectious diseases, chronic diseases and oncology. The company's revenue is mainly derived from sales of pharmaceutical products to distributors in the PRC.
15GF Score

Get the complete analysis for HKSE:06887

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$38.36
Price